NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021
Press Release
Read More
Talking Cancer: Conversations with Trailblazers, Advocates, Patients and Medical Ambassadors
Blog
Read More
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
Press Release
Read More
NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences
Press Release
Read More
TP53/NPM1-Mutated Acute Myeloid Leukemia as a Molecularly Distinct Disease Entity
Literature
Read More